Literature DB >> 8990171

YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene.

B Guo1, F Aslam, A J van Wijnen, S G Roberts, B Frenkel, M R Green, H DeLuca, J B Lian, G S Stein, J L Stein.   

Abstract

The responsiveness of genes to steroid hormones is principally mediated by functional interactions between DNA-bound hormone receptors and components of the transcriptional initiation machinery, including TATA-binding protein, TFIIB, or other RNA polymerase II associated factors. This interaction can be physiologically modulated by promoter context-specific transcription factors to facilitate optimal responsiveness of gene expression to hormone stimulation. One postulated regulatory mechanism involves the functional antagonism between hormone receptors and nonreceptor transcription factors interacting at the same hormone response element. Here we demonstrate that the multifunctional regulator YY1 represses 1,25-dihydroxyvitamin D3 (vitamin D)-induced transactivation of the bone tissue-specific osteocalcin gene. We identify YY1 recognition sequences within the vitamin D response element (VDRE) of the osteocalcin gene that are critical for YY1-dependent repression of vitamin D-enhanced promoter activity. We show that YY1 and vitamin D receptor (VDR)/retinoid X receptor heterodimers compete for binding at the osteocalcin VDRE. In addition, we find that YY1 interacts directly with TFIIB, and that one of the two tandemly repeated polypeptide regions of TFIIB spanning the basic domain is responsible for this interaction. TFIIB and VDR can also interact directly, and these factors synergize to mediate transactivation. Our results suggest that YY1 regulates vitamin D enhancement of osteocalcin gene transcription in vivo by interfering with the interactions of the VDR with both the VDRE and TFIIB.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990171      PMCID: PMC19252          DOI: 10.1073/pnas.94.1.121

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.

Authors:  A Staal; A J van Wijnen; J C Birkenhäger; H A Pols; J Prahl; H DeLuca; M P Gaub; J B Lian; G S Stein; J P van Leeuwen; J L Stein
Journal:  Mol Endocrinol       Date:  1996-11

Review 2.  Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype.

Authors:  G S Stein; J B Lian
Journal:  Endocr Rev       Date:  1993-08       Impact factor: 19.871

3.  The nuclear matrix protein NMP-1 is the transcription factor YY1.

Authors:  B Guo; P R Odgren; A J van Wijnen; T J Last; J Nickerson; S Penman; J B Lian; J L Stein; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

4.  An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene.

Authors:  C Banerjee; S W Hiebert; J L Stein; J B Lian; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

5.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

Review 6.  Osteocalcin. Biochemical considerations and clinical applications.

Authors:  J B Lian; C M Gundberg
Journal:  Clin Orthop Relat Res       Date:  1988-01       Impact factor: 4.176

7.  Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma.

Authors:  R J Majeska; S B Rodan; G A Rodan
Journal:  Endocrinology       Date:  1980-11       Impact factor: 4.736

8.  Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor.

Authors:  I Alroy; T L Towers; L P Freedman
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

9.  A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.

Authors:  Y Kamei; L Xu; T Heinzel; J Torchia; R Kurokawa; B Gloss; S C Lin; R A Heyman; D W Rose; C K Glass; M G Rosenfeld
Journal:  Cell       Date:  1996-05-03       Impact factor: 41.582

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  15 in total

1.  p53 and MDM2 are involved in the regulation of osteocalcin gene expression.

Authors:  Hankui Chen; Kevin Kolman; Natalie Lanciloti; Michael Nerney; Emily Hays; Chet Robson; Nalini Chandar
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

2.  Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone.

Authors:  A Bojesen; N Birkebæk; K Kristensen; L Heickendorff; L Mosekilde; J S Christiansen; C H Gravholt
Journal:  Osteoporos Int       Date:  2010-07-24       Impact factor: 4.507

3.  New insights into the function and regulation of vitamin D target proteins.

Authors:  Sylvia Christakos; Puneet Dhawan; Xiaorong Peng; Alexander G Obukhov; Martha C Nowycky; Bryan S Benn; Yan Zhong; Yan Liu; Qi Shen
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12-22       Impact factor: 4.292

Review 4.  Nuclear microenvironments support physiological control of gene expression.

Authors:  Gary S Stein; Jane B Lian; Martin Montecino; Janet L Stein; André J van Wijnen; Amjad Javed; Jitesh Pratap; Je Choi; S Kaleem Zaidi; Soraya Gutierrez; Kimberly Harrington; Jiali Shen; Daniel Young; Shirwin Pockwinse
Journal:  Chromosome Res       Date:  2003       Impact factor: 5.239

5.  The anti-aging and tumor suppressor protein Klotho enhances differentiation of a human oligodendrocytic hybrid cell line.

Authors:  Ci-Di Chen; Hu Li; Jennifer Liang; Kathryn Hixson; Ella Zeldich; Carmela R Abraham
Journal:  J Mol Neurosci       Date:  2014-06-08       Impact factor: 3.444

Review 6.  Hormone response element binding proteins: novel regulators of vitamin D and estrogen signaling.

Authors:  Thomas S Lisse; Martin Hewison; John S Adams
Journal:  Steroids       Date:  2011-01-13       Impact factor: 2.668

Review 7.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.

Authors:  Sylvia Christakos; Puneet Dhawan; Annemieke Verstuyf; Lieve Verlinden; Geert Carmeliet
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

8.  Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization.

Authors:  A Javed; S Gutierrez; M Montecino; A J van Wijnen; J L Stein; G S Stein; J B Lian
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 9.  Nonclassic actions of vitamin D.

Authors:  Daniel Bikle
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

10.  General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2.

Authors:  Shibing Yu; Yu Jiang; Deborah L Galson; Min Luo; Yumei Lai; Yi Lu; Hong-Jiao Ouyang; Jian Zhang; Guozhi Xiao
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.